Report - Nivolumab in Hodgkin Lymphoma - ercongressi.it · Nivolumab + Ipilimumab – Hodgkin Lymphoma 15 100 0 12 24 36 48 60 72 84 96 −50 −75 100 −25 0 25 50 75 Time since first treatment

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form